相关实验视频
Updated: Sep 16, 2025

09:42
A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model
Published on: June 4, 2021
2.9K
抗β2-糖蛋白I IgG抗体与早期发生的密码性缺血性中风有关
Nina Jaakonmäki1, Tuukka Helin2, Timea Szanto3
1Neurocenter Neurology, Kuopio University Hospital, Finland and University of Eastern Finland, Kuopio, Finland.
European stroke journal
|July 5, 2025
概括
以前未被检测到的抗脂抗体 (aPLs),如抗β2-糖蛋白I (aβ2GPI) 和抗心素 (aCL),与早期发生的密码性缺血性中风 (CIS) 有关. 在这项研究中,狼抗凝剂 (LA) 与CIS没有显著的关联.
科学领域:
- 神经学 神经学
- 免疫学 免疫学 免疫学
- 血管医学 血管医学
背景情况:
- 以前未被检测到的抗脂抗体 (aPLs) 可能解释早期发作的密码性缺血性中风 (CIS).
- 之前对aPL和中风的研究是不确定的,并没有专注于CIS患者.
研究的目的:
- 调查aPLs和早期发作的CIS之间的关联.
- 在CIS患者中评估特定的aPLs,包括狼抗凝剂 (LA),抗心皮素 (aCL) 和抗β2-糖蛋白I (aβ2GPI).
主要方法:
- 这项SECRETO研究招募了503名年龄在18-49岁之间的急性CIS患者,并与无中风的对照进行了匹配.
- 血液样本在基线和12周对患者进行了LA,aCL和aβ2GPIIgG抗体的分析,对照组进行了一次.
- 条件后勤回归模型根据年龄,教育和血管风险因素进行调整,以评估aPL关联.
主要成果:
- 与对照组相比,CIS患者的aβ2GPI阳性频率显著更高 (11.9%对2.0%).
- 阳性aβ2GPI和aCL与CIS相关 (分别为OR 11.22和OR 20.85).
- 阳性aβ2GPI和aCL的频率从基线增加到12周,而LA的频率下降.
结论:
- 阳性抗β2-糖蛋白I (aβ2GPI) 和抗心素 (aCL) 抗体与早期发病的密码性缺血性中风 (CIS) 有关.
- 在这个队列中,狼抗凝剂 (LA) 与CIS没有显著的关联.
- 在中风后,aβ2GPI和aCL的抗体水平增加,而LA水平下降.
相关概念视频
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
41
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
41
Ischemic Heart Disease: Overview
1.4K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.4K
Aneurysm II: Clinical Manifestations and Diagnostic Studies
26
Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
26
Myocarditis II: Clinical Features and Diagnostic Tests
31
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
31
Endocarditis II: Clinical Features of Infective Endocarditis
28
Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
28

